Progesterone 200 MG capsule 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FQHT4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,600
Award facts
- Contract value 100% obligated
- $1,600.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,600 on December 9, 2025, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Progesterone 200 mg capsules (100-count packages). The contract utilizes a firm fixed-price structure with no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement across the Department of Defense.
The PPV-G GEN V program authorizes the Defense Logistics Agency to issue delivery orders for comprehensive pharmaceutical products including prescription medications, over-the-counter drugs, biologics, and medical consumables to support military healthcare facilities worldwide. DMS Pharmaceutical Group's prime vendor contract, valued at $499.999 billion with an ultimate completion date of December 31, 2036, positions the company as a critical regional pharmaceutical supplier for Department of Defense operations. The company's demonstrated performance across numerous delivery orders spanning oncology treatments, biologics, vaccines, and specialty pharmaceuticals substantiates its capability to fulfill diverse medical supply requirements for the federal military medical system, with this Progesterone delivery order serving routine pharmaceutical needs within that broader supply framework.
Quick answers
Who was awarded contract SPE2DR26FQHT4?
SPE2DR26FQHT4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FQHT4 worth?
The government has obligated $1,600 on SPE2DR26FQHT4.
Is contract SPE2DR26FQHT4 an order under another contract?
Yes. SPE2DR26FQHT4 is a delivery order under SPE2DR25D9759, an indefinite delivery contract.
Was contract SPE2DR26FQHT4 competed?
The extent of competition for SPE2DR26FQHT4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award